Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YHD1119 vs Pregabalin in Peripheral Neuropathic Pain
NCT02985216Phase 3Completed
- Sponsor
- Yuhan
- Start
- Feb 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in Peripheral neuropathic pain (2 arms), sponsored by Yuhan. Primary endpoint: Change From Baseline to End of Treatment (EOT) in Weekly Mean Pain Score on the Daily Pain Rating Scale (DPRS) at Day 85. Started Feb 2017; status: completed.
02
Drugs
pregabalin
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT02985216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02985216.